Fmoc-Thr(TBDMS)-OH,
146346-82-9,
Fmoc-O-(tert.-butyldimethylsilyl)-L-threonine,
DTXSID10455249,
(2S,3R)-3-[tert-butyl(dimethyl)silyl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid,
MFCD02092976,
AKOS016014483,
ZINC169748395,
Fmoc-Thr(TBDMS)-OH, >=96.0%,
AS-19669,
ST24047304,
O-(tert-Butyldimethylsilyl)-N-Fmoc-L-threonine,
J-008210,
N-(9H-Fluorene-9-ylmethoxycarbonyl)-O-(tert-butyldimethylsilyl)-L-threonine,
L-Threonine, O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(t-butyl-dimethylsilyl)-L-threonine,
(2S,3R)-3-[(tert-butyldimethylsilyl)oxy]-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoic acid,
FMOC-THR -OH,
CID11102500,
3-(dimethyl-tert-butyl-silyl)oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic Acid,